Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 
 

Latest news from PneumoNP

Every year, the PneumoNP consortium commits to spreading the word about the European Antibiotic Awareness Day that is marked annually on 18 November. During that day organized by the ECDC, a number of initiatives are taking place across Europe to spread the messages on the risks associated with inappropriate use of antibiotics and how to take antibiotics responsibly. Anyone can get involved following their advice.

European Antibiotic Awareness Day 2016

Each year, European Antibiotic Awareness Day's campaigns encourage the prudent use of antibiotics on 18 November. Prudent use means only ...
Read More
infography_figure_for_concept_screen_v04-01

New publication: in vitro testing platform for aerosols

Development of an in vitro testing platform for aerosols containing inhalable antiobiotically active compounds as a part of the EU-project ...
Read More